Niagen Bioscience (NAGE) Non-Current Deferred Tax Liability (2016 - 2019)
Historic Non-Current Deferred Tax Liability for Niagen Bioscience (NAGE) over the last 4 years, with Q4 2019 value amounting to $218000.0.
- Niagen Bioscience's Non-Current Deferred Tax Liability rose 5912.41% to $218000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $218000.0, marking a year-over-year increase of 5912.41%. This contributed to the annual value of $218000.0 for FY2019, which is 5912.41% up from last year.
- Niagen Bioscience's Non-Current Deferred Tax Liability amounted to $218000.0 in Q4 2019, which was up 5912.41% from $137000.0 recorded in Q4 2018.
- In the past 5 years, Niagen Bioscience's Non-Current Deferred Tax Liability ranged from a high of $413000.0 in Q1 2016 and a low of $137000.0 during Q4 2018
- Moreover, its 4-year median value for Non-Current Deferred Tax Liability was $218000.0 (2019), whereas its average is $262200.0.
- In the last 5 years, Niagen Bioscience's Non-Current Deferred Tax Liability plummeted by 6390.98% in 2017 and then surged by 5912.41% in 2019.
- Niagen Bioscience's Non-Current Deferred Tax Liability (Quarter) stood at $399000.0 in 2016, then crashed by 63.91% to $144000.0 in 2017, then decreased by 4.86% to $137000.0 in 2018, then surged by 59.12% to $218000.0 in 2019.
- Its Non-Current Deferred Tax Liability was $218000.0 in Q4 2019, compared to $137000.0 in Q4 2018 and $144000.0 in Q4 2017.